Literature DB >> 12850346

Effect of maternal antibodies on the infant immune response.

W Paul Glezen1.   

Abstract

Transplacentally-acquired antibodies are important for protection of infants in the early months of life. Maternal antibodies may dampen the infant's primary antibody response to infection or immunization. Even without a measurable response to the initial antigen exposure, the infant will usually have evidence of priming at the time of repeat exposure. No evidence for the development of fetal tolerance after immunization during pregnancy has occurred subsequently in infants following active vaccination.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12850346     DOI: 10.1016/s0264-410x(03)00339-6

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  35 in total

Review 1.  Maternal transfer of antibodies in vertebrates: trans-generational effects on offspring immunity.

Authors:  Dennis Hasselquist; Jan-Ake Nilsson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-01-12       Impact factor: 6.237

2.  Determining the persistence of maternally acquired antibodies to hepatitis A and varicella zoster during the first 2 years of life in Turkey.

Authors:  Fırat Begde; Filiz Simsek Orhon; Devran Gerceker; Betul Ulukol; Seda Topcu; Sevgi Baskan
Journal:  Eur J Pediatr       Date:  2015-01-07       Impact factor: 3.183

3.  Maternally transferred anti-factor VIII IgG reduce the anti-factor VIII humoral immune response in factor VIII-deficient mice.

Authors:  Yann Meslier; Sébastien André; Maud Teyssandier; Srinivas V Kaveri; Sébastien Lacroix-Desmazes
Journal:  Immunology       Date:  2010-12       Impact factor: 7.397

Review 4.  Intrinsic Maturational Neonatal Immune Deficiencies and Susceptibility to Group B Streptococcus Infection.

Authors:  Michelle L Korir; Shannon D Manning; H Dele Davies
Journal:  Clin Microbiol Rev       Date:  2017-10       Impact factor: 26.132

5.  The Vi conjugate typhoid vaccine is safe, elicits protective levels of IgG anti-Vi, and is compatible with routine infant vaccines.

Authors:  Vu Dinh Thiem; Feng-Ying C Lin; Do Gia Canh; Nguyen Hong Son; Dang Duc Anh; Nguyen Duc Mao; Chiayung Chu; Steven W Hunt; John B Robbins; Rachel Schneerson; Shousun C Szu
Journal:  Clin Vaccine Immunol       Date:  2011-03-16

6.  Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial.

Authors:  Flor M Munoz; Nanette H Bond; Maurizio Maccato; Phillip Pinell; Hunter A Hammill; Geeta K Swamy; Emmanuel B Walter; Lisa A Jackson; Janet A Englund; Morven S Edwards; C Mary Healy; Carey R Petrie; Jennifer Ferreira; Johannes B Goll; Carol J Baker
Journal:  JAMA       Date:  2014-05-07       Impact factor: 56.272

7.  Development of serum antibodies during early infancy in rhesus macaques: implications for humoral immune responses to vaccination at birth.

Authors:  Ronald S Veazey; Chanjuan Shen; Huanbin Xu; David Liu; Xiaolei Wang
Journal:  Vaccine       Date:  2014-08-01       Impact factor: 3.641

Review 8.  To B or not to B cells-mediate a healthy start to life.

Authors:  T G Nguyen; C M Ward; J M Morris
Journal:  Clin Exp Immunol       Date:  2013-02       Impact factor: 4.330

9.  Safety and immunogenicity of trivalent inactivated influenza vaccine in infants.

Authors:  Natasha B Halasa; Michael A Gerber; Qingxia Chen; Peter F Wright; Kathryn M Edwards
Journal:  J Infect Dis       Date:  2008-05-15       Impact factor: 5.226

Review 10.  Immunization of pregnant women: Future of early infant protection.

Authors:  Azure N Faucette; Michael D Pawlitz; Bo Pei; Fayi Yao; Kang Chen
Journal:  Hum Vaccin Immunother       Date:  2015-09-14       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.